# Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease

> **NCT01559142** · PHASE3 · UNKNOWN · sponsor: **Children's Memorial Health Institute, Poland** · enrollment: 100 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Infliximab with azathioprine (IIFX + AZA)
- **DRUG:** Infliximab (IFX alone)

## Key facts

- **NCT ID:** NCT01559142
- **Lead sponsor:** Children's Memorial Health Institute, Poland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01559142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01559142, "Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01559142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*